The Board of Directors of Biohit Oyj has appointed MA Päivi Siltala the CEO of the company starting September 1, 2021. Siltala is joining Biohit from Johnson & Johnson where she has been Sales Director. Siltala is an experienced biotechnology professional with a large international contact network. She also has a solid track record in managing business development and growth.